JPMorgan Chase & Co’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
Sell
-92
Closed 4501
2016
Q2
$0 Hold
92
﹤0.01% 4569
2016
Q1
$0 Hold
92
﹤0.01% 4496
2015
Q4
$0 Buy
+92
New ﹤0.01% 4265
2013
Q4
Sell
-17,004
Closed -$137K 4016
2013
Q3
$137K Sell
17,004
-4,750
-22% -$38.3K ﹤0.01% 3729
2013
Q2
$159K Buy
+21,754
New +$159K ﹤0.01% 3598